FTC Issues Warning Letter to Covis Pharma
May 22, 2025
May 22, 2025
WASHINGTON, May 22 -- The Federal Trade Commission Bureau of Competition issued the following warning letter on May 21, 2025:
* * *
To: Andrew Teehan, General Counsel, Covis Pharma GMBH, 200 Connell Dr. Berkeley Heights, New Jersey 07922, ateehan@covispharma.com
Re: Improper Orange Book Patent Listings for Tudorza Pressair and Duaklir Pressair
Dear Mr. Teehan,
I write regarding Covis Pharma GMBH's ("Covis") ongoing o . . .
* * *
To: Andrew Teehan, General Counsel, Covis Pharma GMBH, 200 Connell Dr. Berkeley Heights, New Jersey 07922, ateehan@covispharma.com
Re: Improper Orange Book Patent Listings for Tudorza Pressair and Duaklir Pressair
Dear Mr. Teehan,
I write regarding Covis Pharma GMBH's ("Covis") ongoing o . . .